Causalus (private company)

See something wrong or missing? Let us know
Offices:Helsinki
Business model:B2B

Causalus, developed by Pharmanalysis Oy, a software solution solving the challenges related to polypharmacy used for senior patients. The software service comprises of cloud-based software and remote pharmacist service and reviews and monitors medication and its impact.

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 285.5k


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Causalus

Name Criteria
France AbolerIS Pharma
53%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
Denmark AFYX Therapeutics
53%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
Sweden Athera
53%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
Sweden AttgeNO
53%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
Poland Biotts
53%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
Sweden Cinclus Pharma
53%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
Denmark Oui
53%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
Netherlands Citryll
53%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
Sweden Gradientech
53%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
Denmark NMD Pharma
53%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
Top